Comprehensive Aptamer Characterization Platforms

Creative Biolabs' comprehensive aptamer characterization platforms are designed to answer the critical questions that arise after selection and before downstream deployment. We provide advanced structural analytics, quantitative binding assays, thermodynamic profiling, and competition-based specificity assessment.

Submit Your Request Now

Download our service brochure

Inquiry

Why Comprehensive Aptamer Characterization Matters

In early discovery stages, aptamers are often evaluated primarily by apparent affinity. However, as programs advance toward application-driven validation, limitations frequently surface:

Unexpected structural instability under physiological or assay-relevant conditions
Affinity loss when transitioning from purified targets to complex matrices
Cross-reactivity with homologous proteins or pathway-related molecules
Poor performance reproducibility across batches, platforms, or environments

Comprehensive characterization mitigates these risks by generating an integrated performance profile. This approach enables informed go/no-go decisions, rational optimization, and smooth handoff to formulation, assay development, or therapeutic engineering workflows.

Great Minds Choose Creative Biolabs

Partner with Us

Our Comprehensive Aptamer Characterization Platforms

Our platforms consist of four tightly coordinated service modules. Each module can function independently or as part of a full characterization pipeline, depending on project scope and development stage.

Aptamer Structure Analysis

Aptamer function is inseparable from structure. Subtle conformational changes can dramatically alter binding affinity, specificity, and stability. Our structure analysis services focus on elucidating both predicted and experimentally supported conformational features.

Target Binding Characterization

Binding characterization goes far beyond a single affinity constant. Our platform provides quantitative, reproducible measurements that capture the full interaction landscape between aptamers and their targets.

Thermodynamic Profiling

Thermodynamic stability is often the silent determinant of aptamer success or failure. Aptamers that perform well in controlled conditions may falter when exposed to temperature fluctuations, ionic changes, or extended storage.

Competition Assays

In complex biological systems, aptamers rarely act alone. Competition assays reveal how aptamers behave in the presence of endogenous ligands, structurally related molecules, or alternative binders.

Discuss Your Needs

Applications Across Research and Development

Our platform supports a wide range of research scenarios, including:

Aptamer-based diagnostic and biosensor development

Biomarker validation and detection assay optimization

Comparative evaluation of aptamer libraries or variants

Pre-optimization studies prior to chemical modification or conjugation

Start Your Project

Typical Project Workflow & Client Touchpoints

Stage	What We Do	What You Provide
Consultation & Study Design	Clarify target context, application scenario, module selection	Aptamer info (sequence/modifications), target info, intended use
Sample Review & Readiness Check	Confirm sample compatibility and assay feasibility	Aptamer sample + target material (or specs)
Experimental Execution	Run selected module assays under defined conditions
Cross-Module Analysis	Integrate structure/binding/stability/competition interpretation
Reporting & Discussion	Deliver report and walk through outcomes	Feedback/next-stage goals

Design Your Workflow

Deliverables You Receive

Experimental Setup Summary

Defined conditions
Sample requirements
Assay design rationale

Module-Specific Result Package

Structured datasets
Readouts per selected module

Integrated Interpretation Notes

Cross-module correlation insights
Converts raw results into actionable next steps
Candidate comparison summary
Final report

Case Studies

Case 1

The Selection and Characterization of A Novel ssDNA Aptamer Targeting Carcinoembryonic Antigen

Carcinoembryonic antigen (CEA), a well-known cancer biomarker that is used to diagnose various cancers, notably colorectal cancer, was used as a target to select and characterize single-stranded DNA aptamers. In this study, SELEX and NGS techniques were employed in the aptamer selection processes. Aptamer characterization techniques, such as enzyme-linked oligonucleotide assay (ELONA), dot blot, and bioinformatics assays, were conducted to observe the affinity binding of the selected aptamer to the target protein.

The characterization using SELEX, NGS, bioinformatics analysis, ELONA, and confocal microscopy steps. (OA Literature) Fig.1 Schematic overview of CEA aptamer selection and characterization.^1,2

References

Yunussova, Nigara, et al. "A Novel ssDNA Aptamer Targeting Carcinoembryonic Antigen: Selection and Characterization." Biology 11.10 (2022): 1540. https://www.mdpi.com/2079-7737/11/10/1540
Distributed under Open Access license CC BY 4.0, without modification.

What Our Clients Say

"We had several aptamer candidates with comparable affinity values, but the integrated characterization revealed meaningful differences in stability and competitive behavior. That insight allowed us to confidently narrow our shortlist before assay optimization."

— Senior Scientist, Diagnostic Assay Development Team

"The structure analysis helped us understand why certain chemical modifications disrupted binding. Instead of trial-and-error, we were able to refine our design strategy based on solid structural evidence."

—Principal Investigator, Academic Research Laboratory

"What we appreciated most was the way results were contextualized. The report did not just show numbers—it explained what those numbers meant for our intended application."

— R&D Manager, Biotechnology Company

"The competition assays were particularly valuable for us. They highlighted cross-reactivity risks early, saving significant time and resources downstream."

— Project Lead, Life Science CRO

FAQs

Can I select only specific characterization modules instead of the full platform?

Yes. All modules are fully modular. Clients may choose individual services based on immediate research needs or integrate multiple modules into a comprehensive workflow. Many projects begin with one module and expand as development progresses.

How do these services differ from basic affinity testing?

Basic affinity testing provides a single snapshot of binding strength. Our platform expands beyond that by analyzing kinetics, stability, structural integrity, and competitive behavior, offering a multidimensional understanding of aptamer performance that is critical for downstream reliability.

Are chemically modified or labeled aptamers compatible with these assays?

Absolutely. We routinely characterize chemically modified, labeled, and application-specific aptamers. Experimental conditions and analytical approaches are adjusted to accurately assess how modifications impact folding, binding, stability, and specificity.

Can multiple aptamer candidates be compared side by side?

Yes. Comparative characterization is one of the most common use cases. Multiple aptamers can be evaluated under identical conditions, enabling objective ranking and evidence-based candidate prioritization.

Are assays performed under physiologically or application-relevant conditions?

Where appropriate, assays can be conducted under conditions that mimic physiological or application-specific environments, such as defined ionic strength, temperature ranges, or buffer systems, to enhance translational relevance.

What does the final report include?

Each project includes a structured, presentation-ready report with experimental summaries, module-specific results, integrated interpretation, and application-oriented conclusions. Reports are designed to support internal review, decision-making, and downstream planning.

Can results from this platform support optimization or redesign of aptamers?

Yes. By correlating structural features with binding behavior, stability, and competition outcomes, our data often highlights specific optimization opportunities—such as sequence refinement, modification strategy adjustments, or condition tuning—reducing reliance on trial-and-error approaches.